Cargando…

Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer

INTRODUCTION: Circulating tumor DNA (ctDNA) testing may identify patients at high risk for recurrence following chemoradiation (CRT) for locally advanced non-small cell lung cancer (LA-NSCLC). We evaluated the feasibility of ctDNA testing on a readily available commercial fixed-gene panel to predict...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knapp, Brendan, Mezquita, Laura, Devarakonda, Siddhartha, Aldea, Mihaela, Waqar, Saiama N., Pepin, Kym, Ward, Jeffrey P., Botticella, Angela, Howarth, Karen, Knape, Charlene, Morris, Clive, Govindan, Ramaswamy, Besse, Benjamin, Morgensztern, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000093/ https://www.ncbi.nlm.nih.gov/pubmed/35419282 http://dx.doi.org/10.3389/fonc.2022.856132

Ejemplares similares

A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations
por: Devarakonda, Siddhartha, et al.
Publicado: (2021)

Bone metastases in non-small cell lung cancer: a narrative review
por: Knapp, Brendan J., et al.
Publicado: (2022)

Untangling the evolutionary roots of lung cancer
por: Devarakonda, Siddhartha, et al.
Publicado: (2019)

Management of patients with advanced non-small cell lung cancer: role of gefitinib
por: Velcheti, Vamsidhar, et al.
Publicado: (2010)

Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors
por: Bagegni, Nusayba A., et al.
Publicado: (2022)

Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer
por: Semenkovich, Nicholas P., et al.
Publicado: (2023)

Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer
por: Semenkovich, Nicholas P., et al.
Publicado: (2023)

Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014
por: Trikalinos, Nikolaos A., et al.
Publicado: (2020)

The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups in advanced non-small cell lung cancer (NSCLC) patients
por: Aldea, Mihaela, et al.
Publicado: (2020)

Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case report
por: Aldea, Mihaela, et al.
Publicado: (2022)

Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer()
por: Levy, Antonin, et al.
Publicado: (2023)

Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer
por: Schernberg, Antoine, et al.
Publicado: (2018)

Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
por: Wagner, Alex H., et al.
Publicado: (2018)

A four specimen-pooling scheme reliably detects SARS-CoV-2 and influenza viruses using the BioFire FilmArray Respiratory Panel 2.1
por: Ranadheera, Charlene, et al.
Publicado: (2022)

Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience
por: Botticella, Angela, et al.
Publicado: (2019)

RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer
por: Morgensztern, Daniel, et al.
Publicado: (2019)

Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer patients
por: Fung, Andrea S., et al.
Publicado: (2021)

Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176
por: Auclin, Edouard, et al.
Publicado: (2021)

Manual Washington® de oncología /
por: Govindan, Ramaswamy
Publicado: (2016)

Meningeal “Lazarus Response” to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib
por: Facchinetti, Francesco, et al.
Publicado: (2021)

Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases
por: Bakker, Erik N. T. P., et al.
Publicado: (2016)

Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
por: Scagliotti, Giorgio, et al.
Publicado: (2010)

Molecular profile of lung cancer in never smokers
por: Subramanian, Janakiraman, et al.
Publicado: (2013)

Herbalists and the Panels
por: Ward, Gordon P.
Publicado: (1913)

Radon and Lung Cancer: Current Trends and Future Perspectives
por: Riudavets, Mariona, et al.
Publicado: (2022)

表皮生长因子/HER2抑制剂在非小细胞肺癌患者治疗中的作用综述
por: GOVINDAN, Ramaswamy, et al.
Publicado: (2010)

De novo serine biosynthesis from glucose predicts sex-specific response to antifolates in non-small cell lung cancer cell lines
por: Sponagel, Jasmin, et al.
Publicado: (2022)

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)
por: Morgensztern, Daniel, et al.
Publicado: (2021)

Estimation of poverty bounds for Pakistan using synthetic panel data
por: Shabnam, Nadia, et al.
Publicado: (2023)

Sympathetic nerves control bacterial clearance
por: Lankadeva, Yugeesh R., et al.
Publicado: (2020)

Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay
por: Remon, Jordi, et al.
Publicado: (2020)

The contribution of apixaban renal clearance to total clearance
por: Frost, Charles, et al.
Publicado: (2015)

67/m – progrediente Luftnot bei einem Raucher mit Magenkarzinom: Vorbereitung auf die Facharztprüfung: Fall 39
por: Knape, P.
Publicado: (2021)

63/w mit unklarer Luftnot: Vorbereitung auf die Facharztprüfung: Fall 67
por: Knape, Philipp
Publicado: (2021)

Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?
por: Tomuleasa, Ciprian, et al.
Publicado: (2013)

Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer
por: Hassanzadeh, Comron, et al.
Publicado: (2020)

Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents
por: Zhang, Tan, et al.
Publicado: (2023)

Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer
por: Pritchett, Michael A., et al.
Publicado: (2019)

Determinación del intervalo al estro y el porcentaje de gestación después de la aplicación de 500 mcg. de Cloprostenol (PGF2&) en ganado Bos taurus x Bos indicus bajo clima tropical subhúmedo /
por: Knape Macías, Otto
Publicado: (1992)

The Triple Jags of Dietary Fibers in Cereals: How Biotechnology Is Longing for High Fiber Grains
por: Botticella, Ermelinda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_50d015mgr69pl9td9ol74pf2cb